Brimonidine en es it fr

Brimonidine Brand names, Brimonidine Analogs

Brimonidine Brand Names Mixture

  • None

Brimonidine Chemical_Formula


Brimonidine RX_link

Brimonidine fda sheet

Brimonidine FDA

Brimonidine msds (material safety sheet)

Brimonidine MSDS

Brimonidine Synthesis Reference

M. B. Thomas, M. T. Williams, Ger. Pat. 2,538,630 (1976 to Pfizer)

Brimonidine Molecular Weight

292.135 g/mol

Brimonidine Melting Point

207.5 oC

Brimonidine H2O Solubility

Soluble (1.5 mg/mL)

Brimonidine State


Brimonidine LogP


Brimonidine Dosage Forms

0.2% solution

Brimonidine Indication

For the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Brimonidine Pharmacology

Brimonidine significantly lowers intraocular pressure with minimal effects on cardiovascular and pulmonary parameters. It lowers intraocular pressure by reducing aqueous humor production and increasing uveoscleral outflow.

Brimonidine Absorption

Minimal systemic absorption occurs after ocular insertion.

Brimonidine side effects and Toxicity

Oral LD50 is 50 mg/kg in mice and 100 mg/kg in rats.

Brimonidine Patient Information

Brimonidine tartrate is used for the treatment of open-angle glaucoma and ocular hypertension. Do not take this drug if you are currently taking MAO Inhibitors (e.g., Parnate). Inform your doctor if you are pregnant or nursing.
This product may stain soft contact lenses. Wait at least 15 minutes after instilling brimonidine to insert contact lenses.
May cause drowsiness or tiredness; use caution while driving or operating hazardous machinery. May cause dry mouth, blurring, stinging, or burning of the eyes; headaches, fatigue or drowsiness; allergic or itching of the eyes. Tell your doctor or pharmacist if these effects occur.

Brimonidine Organisms Affected

Humans and other mammals